Clinicopathological and prognostic significance of microRNA-107 and its relationship to DICER1 mRNA expression in gastric cancer

Oncology Reports

Volumn 27, Issue 6, 2012, Pages 1759-1764

  Inoue, Taisuke ^a   Iinuma, Hisae ^a   Ogawa, Etsushi ^a   Inaba, Tsuyoshi ^a   Fukushima, Ryoji ^a  

^a TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

DICER1; Gastric cancer; microRNA 107; Prognosis; Recurrence

Indexed keywords

MESSENGER RNA; MICRORNA; MICRORNA 107; MICRORNA 142 3P; MICRORNA 150; MICRORNA 17; MICRORNA 191; MICRORNA 196A; MICRORNA 21; MICRORNA 26B; MICRORNA 30B; MICRORNA 9; UNCLASSIFIED DRUG;

ARTICLE; CANCER INVASION; CANCER LOCALIZATION; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; DICER1 GENE; DISEASE FREE SURVIVAL; DOWN REGULATION; GENE EXPRESSION REGULATION; GENE LOCATION; GENE OVEREXPRESSION; GENE TARGETING; GENETIC ASSOCIATION; GENETIC MARKER; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; ONCOGENE; OVERALL SURVIVAL; PREDICTION; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; STOMACH CANCER; TISSUE MICROARRAY; UPREGULATION;

ADULT; AGED; AGED, 80 AND OVER; DEAD-BOX RNA HELICASES; DISEASE-FREE SURVIVAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYMPHATIC METASTASIS; MALE; MICRORNAS; MIDDLE AGED; RIBONUCLEASE III; RNA, MESSENGER; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84860746857     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2012.1709     Document Type: Article

References (27)

1. Uemura N, Okamoto S, Yamamoto S, et al: Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 345: 784-789, 2001.
2. Crew KD and Neugut AI: Epidemiology of gastric cancer. World J Gastroenterol 12: 354-362, 2006. (Pubitemid 43329250)
3. Medina PP and Slack FJ: microRNA and cacer: an overview. Cell Cycle 7: 2485-2492, 2008.
4. Paranjape T, Slack FJ and Weidhaas JB: MicroRNAs: tools for cancer diagnostics. Gut 58: 1546-1554, 2009.
5. Esquela-Kerscher A and Slack FJ: Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 6: 259-269, 2006.
6. Chen CZ, Li L, Lodish HF and Bartel DP: MicroRNAs modulate hematopoietic lineage differentiation. Science 303: 83-86, 2004. (Pubitemid 38055775)
7. Croce CM and Calin GA: miRNAs cancer and stem cell division.Cell 122: 6-7, 2005. (Pubitemid 40977933)
8. Mattick JS and Makunin IV: Non-coding RNA. Hum Mol Genet 15: R17-R29, 2006.
9. Bartel DP: MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297, 2004.
10. Volinia S, Calin GA, Liu CG, et al: A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 103: 2257-2261, 2006. (Pubitemid 43271657)
11. Huang XH, Wang Q, Chen JS, et al: Bead-based microarray analysis of microRNA expression in hepatocellular carcinoma: miR-338 is downregulated. Hepathol Res 39: 786-794, 2009.
12. Guo Y, Chen A, Zhang L, et al: Distinctive microRNA profiles relating to patient survival in esophageal squamous cell carcinoma. Cancer Res 68: 26-33, 2008. (Pubitemid 351380102)
13. Li X, Zhang Y, Shi Y, et al: MicroRNA-107, an oncogene microRNA that regulates tumor invasion and metastasis by targeting DICER1 in gastric cancer. J Cell Mol Med 15: 1887-1895, 2011.
14. Li X, Zhang Y, Ding J, et al: Survival prediction of gastric cancer by a seven-microRNA signature. Gut 59: 579-585, 2010.
15. Lu J, Getz G, Miska EA, et al: MicroRNA expression profiles classify human cancers. Nature 435: 834-838, 2005. (Pubitemid 40839735)
16. Lee KH, Lotterman C, Karikari C, et al: Epigenetic silencing of microRNA-107 regulates cyclin-dependent kinase 6 expression in pancreatic cancer. Pancreatology 9: 293-301, 2009.
17. Takahashi Y, Forrest ARR, Maeno E, et al: MiR-107 and mir-185 can induce cell cycle arrest in human non-small cell lung cancer cell lines. PLoS One 4: 1-9, 2009.
18. Yamakuchi M, Lotterman CD, Bao C, et al: p53-induced microRNA-107 inhibits HIF-1 and tumor angiogenesis. Proc Natl Acad Sci USA 107: 6334-6339, 2010.
19. Karube Y, Tanaka H, Osada H, et al: Reduced expression of Dicer is associated with poor prognosis in lung cancer patients. Cancer Sci 96: 111-115, 2005. (Pubitemid 40425386)
20. Merritt WM, Lin YG, Han LY, et al: Dicer, Drosha, and outcomes in patients with ovarian cancer. N Engl J Med 359: 2641-2650, 2008.
21. Chiosea S, Jelezcova E, Chandran U, et al: Up-regulation of dicer, a component of the microRNA machinery, in prostate adenocarcinoma. Am J Pathol 169: 1812-1820, 2006. (Pubitemid 351182010)
22. Chiosea S, Jelezcova E, Chandran U, et al: Overexpression of Dicer in precursor lesions of lung adenocarcinoma. Cancer Res 67: 2345-2350, 2007. (Pubitemid 46424256)
23. Shibuya H, Iinuma H, Shimada R, et al: Clinicopathological and prognostic value of microRNA-21 and microRNA-155 in colorectal cancer. Oncology 79: 313-320, 2010.
24. Hwang HW and Mendell JT: MicroRNAs in cell proliferation, cell death, and tumorigenesis. Br J Cancer 94: 776-780, 2006.
25. Kumar MS, Pester RE, Chen CY, et al: Dicer1 functions as a haploinsufficient tumor suppressor. Genes Dev 23: 2700-2704, 2009.
26. Zighelboim I, Reinhart AJ, Gao F, et al: DICER1 expression and outcome in endometrioid endometrial adenocarcinoma. Cancer 117: 1446-1453, 2011.
27. Zheng ZH, Sun XJ, Fu WN, et al: Decreased expression of DICER1 in gastric cancer. Chin Med J 120: 2099-2104, 2007. (Pubitemid 350268157)